Tilray Brands Acquires Anheuser-Busch Beer Portfolio

Ticker: TLRY · Form: 8-K · Filed: 2025-02-07T00:00:00.000Z

Sentiment: neutral

Topics: acquisition, diversification, consumer-goods

Related Tickers: BUD

TL;DR

Tilray just bought a bunch of beer brands from AB InBev to expand beyond weed.

AI Summary

Tilray Brands, Inc. announced on February 5, 2025, that it has entered into a definitive agreement to acquire a portfolio of beer brands from Anheuser-Busch InBev SA/NV. The acquisition includes brands such as Shock Top, Blue Point Brewing, Devils Backbone Brewing, and others, significantly expanding Tilray's beverage alcohol business. This move is expected to enhance Tilray's market presence and diversify its revenue streams within the consumer packaged goods sector.

Why It Matters

This acquisition marks a significant diversification for Tilray Brands beyond its core cannabis business, aiming to leverage established beer brands for broader consumer reach and revenue growth.

Risk Assessment

Risk Level: medium — The acquisition involves integrating new brands and operations, which carries inherent execution risks and potential impacts on financial performance.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Tilray Brands, Inc.?

This 8-K filing announces Tilray Brands, Inc.'s entry into a definitive agreement to acquire a portfolio of beer brands from Anheuser-Busch InBev SA/NV.

Which specific beer brands are included in the acquisition by Tilray Brands?

The acquisition includes brands such as Shock Top, Blue Point Brewing, and Devils Backbone Brewing, among others.

What is the date of the reported event?

The earliest event reported is February 5, 2025.

What is Tilray Brands, Inc.'s primary business sector?

Tilray Brands, Inc. is primarily known for its operations in the medicinal chemicals and botanical products sector (SIC code 2833), with this acquisition expanding into the beverage alcohol business.

What is the filing date of this 8-K report?

This 8-K report was filed as of February 7, 2025.

From the Filing

0001437749-25-003171.txt : 20250207 0001437749-25-003171.hdr.sgml : 20250207 20250207163134 ACCESSION NUMBER: 0001437749-25-003171 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250205 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250207 DATE AS OF CHANGE: 20250207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 25602359 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 tlry20250129_8k.htm FORM 8-K tlry20220918_8k.htm false 0001731348 0001731348 2025-02-05 2025-02-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025     Tilray Brands, Inc. (Exact name of Registrant as Specified in Its Charter)     Delaware 001-38594 82-4310622 (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.)       265 Talbot Street West ,     Leamington , ON   N8H 5L4 (Address of Principal Executive Offices,   (Zip Code)   Registrant’s Telephone Number, Including Area Code: ( 844 ) 845-7291   Not applicable (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Name of each exchange on which registered   Symbol(s)   Common Stock , $0.0001 par TLRY   value per share   The Nasdaq Global Select Market         Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 8.01           Other Events.   Successful Settlement of Aphria Canadian Class Action and Related Individual Actions   In February 2019, a putative securities class action was commenced in the Ontario Superior Court of Justice against Tilray Brands’ wholly-owned subsidiary, Aphria, Inc. (“ Aphria ”), and certain of its former officers and directors (the “ Aphria Canadian Class Action ”). The Aphria Canadian Class Action was subsequently amended in September 2022 to proceed only again

View on Read The Filing